Inactive Instrument

Highlights OYSR POIN

Equities

OYST

US69242L1061

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Viatris Completes Acquisitions of Oyster Point Pharma, Famy Life Sciences	03/01/23	MT
Oyster Point Pharma, Inc. Announces Board Resignations	03/01/23	CI
Viatris Inc. completed the acquisition of Oyster Point Pharma, Inc. from a group of shareholders.	02/01/23	CI
Earnings Flash (OYST) OYSTER POINT PHARMA Reports Q3 Revenue $5.6M	10/11/22	MT
Oyster Point Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Health Care Up Amid Deal Activity -- Health Care Roundup	07/11/22	DJ
Viatris Affirms 2022 Outlook After Third-Quarter Earnings Beat, Signs Deal to Buy Oyster Point Pharma	07/11/22	MT
Oyster Point Pharma Climbs Amid $11/Share Takeover Deal With Viatris	07/11/22	MT
Viatris to Buy Oyster Point Pharma, Famy Life Sciences	07/11/22	MT
Oyster Point Pharma, Inc.’s Board intends to launch Stock Repurchase Program.	07/11/22	CI
Viatris Inc. entered into a definitive agreement to acquire Oyster Point Pharma, Inc. from a group of shareholders for approximately $320 million.	06/11/22	CI
Oyster Point Pharma Says Tyrvaya Nasal Spray to Be Covered by Medicare Pharmacy Benefit Manager	17/08/22	MT
Oyster Point Pharma Announces Tyrvaya® to Be Covered by the Larger Medicare Pharmacy Benefit Manager	17/08/22	CI
Oyster Point Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Earnings Flash (OYST) OYSTER POINT PHARMA Posts Q2 Revenue $4.7M, vs. Street Est of $4.87M	11/08/22	MT
Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA	27/07/22	CI
Earnings Flash (OYST) OYSTER POINT PHARMA Reports Q1 Revenue $2.7M, vs. Street Est of $1.83M	05/05/22	MT
Earnings Flash (OYST) OYSTER POINT PHARMA Reports Q1 Loss $-1.80, vs. Street Est of $-1.74	05/05/22	MT
Oyster Point Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/05/22	CI
Oyster Point Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights OYSR POIN

Equities

OYST

US69242L1061

Highlights

Filters